Former banker named VP of investments for Empire Corporate

ALBANY, N.Y. - The credit union industry is becoming the home to more and more former bankers. Empire Corporate FCU announced that it has named Dan Haglund Vice President of Investments. Haglund will be responsible for managing Empire Corporate's $2.6 billion investment portfolio. Haglund was formerly Chief Investment Officer and...

By Staff Writer | January 15, 2002 at 07:00 PM

<p>ALBANY, N.Y. – The credit union industry is becoming the home to more and more former bankers. Empire Corporate FCU announced that it has named Dan Haglund Vice President of Investments. Haglund will be responsible for managing Empire Corporate's $2.6 billion investment portfolio. Haglund was formerly Chief Investment Officer and Treasurer at Harrington Bank in Richmond, Indiana. He has over 16 years of financial institution experience</p>

Continue Reading for Free

Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
Educational webcasts, white papers, and ebooks from industry thought leaders
Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor

NOT FOR REPRINT

1 5 wealthy nations with the worst health care access

2 Best and worst areas for retiree health benefits access in 2024

Insurance
BenefitsPRO Broker Expo 2025 (BPRO)
May 06, 2025 - Boston

The premier educational and networking event for employee benefits brokers and agents.
More Information
GlobeSt. Multifamily Fall 2024
October 15, 2024 - Los Angeles

Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
More Information
Credit Union Times Luminaries Awards 2024
November 07, 2024 - Orlando

This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
More Information

FTC sues three largest UnitedHealth, Cigna, and CVS over high insulin prices

By Maydeen Merino | September 23, 2024

"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed," said Rahul Rao, deputy director of the FTC's Bureau of Competition.